Jianerkang Medical Co.,Ltd. (SHA:603205)

China · Delayed Price · Currency is CNY

21.08

0.00 (0.00%)

At close: Aug 4, 2026

Jianerkang Medical Financials Overview

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	1,022	1,024	1,046	1,034	1,093	782.04
Revenue Growth	-4.95%	-2.04%	1.18%	-5.46%	39.79%	-51.83%
Gross Profit	241.66	242.62	233.37	230.92	258.43	181.97
Operating Income	122.74	118.25	120.64	126.18	142.36	100.98
Net Income	110.11	111.44	120.22	123.55	157.34	131.63
Earnings Per Share	0.71	0.71	0.97	1.05	1.34	1.13
EPS Growth	-22.77%	-26.80%	-7.95%	-21.64%	19.54%	-69.53%

Revenue by Geography

Fiscal Year	FY 2025
Period Ending	Dec '25 Dec 31, 2025
China	114.16
Export	910.23
Total	1,024

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	772.39	764.91	721.81	226.24	178.25	97.8
Total Debt	19.06	21.76	-	-	30.04	50.05
Net Cash (Debt)	753.33	743.15	721.81	226.24	148.21	47.75
Net Cash Growth	0.73%	2.96%	219.05%	52.65%	210.40%	89.99%
Net Cash Per Share	4.86	4.73	5.82	1.93	1.27	0.41

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	147.92	158.79	141.1	157.8	163.01	70.6
Capital Expenditures	-73.03	-69.98	-39.75	-84.18	-66.32	-48.64
Free Cash Flow	74.89	88.81	101.35	73.62	96.7	21.96
Free Cash Flow Growth	0.15%	-12.38%	37.66%	-23.86%	340.34%	-94.07%

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	23.66%	23.69%	22.32%	22.34%	23.64%	23.27%
Operating Margin	12.02%	11.54%	11.54%	12.21%	13.02%	12.91%
Pretax Margin	12.23%	12.34%	13.17%	13.80%	16.27%	19.13%
Profit Margin	10.78%	10.88%	11.50%	11.95%	14.39%	16.83%
FCF Margin	7.33%	8.67%	9.69%	7.12%	8.85%	2.81%

Dividends

Fiscal Year	Current	FY 2025	FY 2024
Period Ending	Aug '26 Aug 4, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Dividend Per Share	0.250	0.250	0.351
Dividend Per Share Growth	0%	-28.78%	-
Dividend Yield	1.19%	0.89%	1.22%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 4, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	29.70	40.02	38.21	-	-	-
P/FCF Ratio	43.91	50.22	45.32	-	-	-
PS Ratio	3.22	4.35	4.39	-	-	-